返回 Agenda
LS51 Next-Generation Digital Healthcare Considering Pre-Symptomatic State, Prevention, and Well-Being (Part 2)
Session Chair(s)
Takashi Moriya, PHD, MBA
Research Fellow
Keio University, KBS (Keio Business School) Graduate School, Japan
Speaker(s)
Takeru Hiki
Welby Inc, Japan
CEO
Hiroyuki Idone
Novo Nordisk Pharma Ltd., Japan
Digital Health Program Lead